PET monitoring of cancer therapy with He-3 and C-12 beams: a study with the GEANT4 toolkit

preprint2007arXivOpen access

Abstract

We study the spatial distributions of β+β^+-activity produced by therapeutic beams of 3^3He and 12^{12}C ions in various tissue-like materials. The calculations were performed within a Monte Carlo model for Heavy-Ion Therapy (MCHIT) based on the GEANT4 toolkit. The contributions from 10,11^{10,11}C, 13^{13}N, 14,15^{14,15}O, 17,18^{17,18}F and 30^{30}P positron-emitting nuclei were calculated and compared with experimental data obtained during and after irradiation. Positron emitting nuclei are created by 12^{12}C beam in fragmentation reactions of projectile and target nuclei. This leads to a β+β^+-activity profile characterised by a noticeable peak located close to the Bragg peak in the corresponding depth-dose distribution. On the contrary, as the most of positron-emitting nuclei are produced by 3^3He beam in target fragmentation reactions, the calculated total β+β^+-activity during or soon after the irradiation period is evenly distributed within the projectile range. However, we predict also the presence of 13^{13}N, 14^{14}O, 17,18^{17,18}F created in charge-transfer reactions by low-energy 3^3He ions close to the end of their range in several tissue-like media. The time evolution of β+β^+-activity profiles was investigated for both kinds of beams. Due to the production of 18^{18}F nuclide the β+β^+-activity profile measured 2 or 3 hours after irradiation with 3^{3}He ions will have a distinct peak correlated with the maximum of depth-dose distribution. We found certain advantages of low-energy 3^{3}He beams over low-energy proton beams for reliable PET monitoring during particle therapy of shallow located tumours. In this case the distal edge of β+β^+-activity distribution from 17^{17}F nuclei clearly marks the range of 3^{3}He in tissues.

Explore this paper’s authors, topics and related work.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Reviews 0

Write a reviewWrite

No reviews yet.

Discussion 0

Add a commentWrite

No comments yet.